The expression of Survivin gene in cholangiocarcinoma and its correlation with bcl-2, bax
Yong Zhou, Yuan Liu
Abstract
Yong Zhou, Yuan Liu
Abstract
Objective To study the expression of Survivin gene and its relationship with the ex-pression of bcl-2, and bax proteins in cholangiocarcinoma. Methods The expression of Survivin mRNA was detected by using reverse transcriptase polymerase chain reaction (RT-PCR) in 64 cases of cholangio- carinoma tissue,22 cases of paracarcinoma tissue,and 10 cases of normal bile duct tissue. The expression of bcl-2,and bax proteins in cholangiocarcinoma was detected by immunohistochemical assay. Results The expression rate of Survivin mRNA in cholangiocarcinoma was 65.6% (42/64), which was obviously higher than that in paracarcinoma tissue(9.1%, P 0.05 ). The expression rate of bcl-2, and bax protein in cholangiocarcinoma was 56.3% (36/64), and 45.3% (29/64) respectively. There was a positive correlation between the expression of Survivin and bcl-2 (r =0.404 ,P < 0. 01),whereas a negative correlation between the expression of Survivin and bax(r = - 0.373, P < 0.01 ). Conclusion Survivin gene may play an important role in the pathogenesis and development of cholangiocarcinoma. Sur- vivin gene may be a new target for gene therapy of cholangiocarcinoma. Survivin and bcl-2, bax have a syn- ergic or antagonistic role respectively during the pathogenesis of cholangiocarcinoma. Key words: Cancer of biliary duct ; Survivin; bel-2; bax
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression of Survivin gene and its relationship with the ex-pression of bcl-2, and bax proteins in cholangiocarcinoma. Methods The expression of Survivin mRNA was detected by using reverse transcriptase polymerase chain reaction (RT-PCR) in 64 cases of cholangio- carinoma tissue,22 cases of paracarcinoma tissue,and 10 cases of normal bile duct tissue. The expression of bcl-2,and bax proteins in cholangiocarcinoma was detected by immunohistochemical assay. Results The expression rate of Survivin mRNA in cholangiocarcinoma was 65.6% (42/64), which was obviously higher than that in paracarcinoma tissue(9.1%, P 0.05 ). The expression rate of bcl-2, and bax protein in cholangiocarcinoma was 56.3% (36/64), and 45.3% (29/64) respectively. There was a positive correlation between the expression of Survivin and bcl-2 (r =0.404 ,P < 0. 01),whereas a negative correlation between the expression of Survivin and bax(r = - 0.373, P < 0.01 ). Conclusion Survivin gene may play an important role in the pathogenesis and development of cholangiocarcinoma. Sur- vivin gene may be a new target for gene therapy of cholangiocarcinoma. Survivin and bcl-2, bax have a syn- ergic or antagonistic role respectively during the pathogenesis of cholangiocarcinoma. Key words: Cancer of biliary duct ; Survivin; bel-2; bax
Key concepts: Survivin, Messenger RNA, Cancer research, Immunohistochemistry, Gene, Gene expression, Intrahepatic Cholangiocarcinoma, Bile duct